Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Novartis To Acquire Alcon | Contract Pharma

What are you searching for?

Sign in
Breaking News

Novartis To Acquire Alcon

Novartis will acquire majority control of Alcon, Inc., entering an all-share direct merger with Alcon for the remaining the 23% stake it did not previously own.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Novartis will acquire majority control of Alcon, Inc., entering an all-share direct merger with Alcon for the remaining the 23% stake it did not previously own. The move completes Novartis’ April 2008 agreement with Nestlé S.A. that led to Novartis taking a 77% in Alcon.

“The addition of Alcon will strategically strengthen our healthcare portfolio and our position in eye care, a sector with dynamic growth due to the increasing patient needs of an aging population,” said Dr. Daniel Vasella, chairman and chief executive officer of Novartis. “This is the right time to simplify Alcon’s ownership to eliminate uncertainties for employees and shareholders. It will also allow us to strengthen innovation power by combining R&D efforts and grow our global market presence thanks to our complementary product portfolios.”

Alcon and Novartis both have eye care businesses that together cover more than 70% of the global vision care sector. Alcon, which is incorporated in Switzerland and has U.S. operations based in Fort Worth, TX, has three business sectors: Surgical including medical devices and ophthalmic surgery products; Pharmaceuticals that includes specialty medicines for various eye diseases; and consumer products consisting of contact lens care, OTC dry eye drops and ocular vitamins.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters